Doping control analysis of selected peptide hormones using LC-MS(/MS).
暂无分享,去创建一个
[1] M. Thevis,et al. Comprehensive plasma-screening for known and unknown substances in doping controls. , 2010, Rapid communications in mass spectrometry : RCM.
[2] M. Thevis,et al. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. , 2010, Drug testing and analysis.
[3] M. Thevis,et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[4] Wilhelm Schänzer,et al. Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. , 2009, Drug testing and analysis.
[5] G. Ball,et al. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. , 2009, Rapid communications in mass spectrometry : RCM.
[6] M. Thevis,et al. Detection of His-tagged Long-R³-IGF-I in a black market product. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[7] M. Thevis,et al. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[8] P H Sonksen. HORMONES AND SPORT Insulin, growth hormone and sport , 2001 .
[9] E. Travis Littledike,et al. Insulin , 1923, The Indian medical gazette.
[10] Peter H. Sönksen,et al. Insulin, growth hormone and sport. , 2001 .
[11] E. Arvat,et al. Growth hormone-releasing peptides. , 1997, European journal of endocrinology.
[12] Prabha Dwivedi,et al. Ion mobility-mass spectrometry. , 2008, Journal of mass spectrometry : JMS.
[13] P. Hemmersbach,et al. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.
[14] Wilhelm Schänzer,et al. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. , 2005, Analytical chemistry.
[15] M. Thevis,et al. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. , 2010, Drug testing and analysis.
[16] D. Cowan,et al. Peptide hormones and sport: misuse and detection. , 1992, British medical bulletin.
[17] K. Rose,et al. Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay* , 1997, The Journal of Biological Chemistry.
[18] P. Sönksen,et al. Growth hormone, IGF‐I and insulin and their abuse in sport , 2008, British journal of pharmacology.
[19] Wilhelm Schänzer,et al. Mass spectrometric identification of peptide hormones in doping-control analysis. , 2007, The Analyst.
[20] M. Thevis. Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays , 2010 .
[21] B. Swanepoel,et al. Growth hormone abuse in the horse: preliminary assessment of a mass spectrometric procedure for IGF-1 identification and quantitation. , 2001, Rapid communications in mass spectrometry : RCM.
[22] J. Tabet,et al. Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry , 2008, Analytical and bioanalytical chemistry.
[23] S. Kageyama,et al. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.
[24] Wilhelm Schänzer,et al. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. , 2006, Analytical chemistry.
[25] S. Kageyama,et al. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[26] Wilhelm Schänzer,et al. Mass spectrometric determination of insulins and their degradation products in sports drug testing. , 2008, Mass spectrometry reviews.
[27] G. Lubec,et al. Mass spectrometrical analysis of recombinant human growth hormone (Genotropin®) reveals amino acid substitutions in 2% of the expressed protein , 2005, Proteome Science.
[28] M. Thevis,et al. Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant , 2010, Pediatrics.
[29] M J Chamberlain,et al. The renal handling of insulin. , 1967, The Journal of clinical investigation.
[30] Wilhelm Schänzer,et al. Current role of LC-MS(/MS) in doping control , 2007, Analytical and bioanalytical chemistry.
[31] Ruedi Aebersold,et al. Mass spectrometry based targeted protein quantification: methods and applications. , 2009, Journal of proteome research.
[32] M. Thevis,et al. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. , 2007, Analytical chemistry.
[33] M. T. A. W. Schanzer. Identification and Characterization of Peptides and Proteins in Doping Control Analysis , 2005 .
[34] M. Miller,et al. A mass spectrometric method for quantitation of intact insulin in blood samples. , 2001, Journal of analytical toxicology.
[35] R. Holt. Detecting growth hormone abuse in athletes. , 2009, Drug testing and analysis.
[36] I. Erotokritou-Mulligan,et al. Insulin-like growth factor I and insulin and their abuse in sport. , 2010, Endocrinology and metabolism clinics of North America.
[37] R. Yalow,et al. Methods for concentration of urinary immunoreactive insulin. , 1986, Journal of Korean medical science.
[38] M. Thevis,et al. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. , 2011, The Analyst.